Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

MLA

Widmark, Anders, et al. “Endocrine Treatment, with or without Radiotherapy, in Locally Advanced Prostate Cancer (SPCG-7/SFUO-3): An Open Randomised Phase III Trial.” The Lancet, vol. 373, no. 9660, Jan. 2009, pp. 301–08. EBSCOhost, https://doi.org/10.1016/S0140-6736(08)61815-2.

APA

Widmark, A., Klepp, O., Solberg, A., Damber, J.-E., Angelsen, A., Fransson, P., Lund, J.-Å., Tasdemir, I., Hoyer, M., Wiklund, F., & Fosså, S. D. (2009). Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. The Lancet, 373(9660), 301–308. https://doi.org/10.1016/S0140-6736(08)61815-2

Chicago

Widmark, Anders, Olbjørn Klepp, Arne Solberg, Jan-Erik Damber, Anders Angelsen, Per Fransson, Jo-Åsmund Lund, et al. 2009. “Endocrine Treatment, with or without Radiotherapy, in Locally Advanced Prostate Cancer (SPCG-7/SFUO-3): An Open Randomised Phase III Trial.” The Lancet 373 (9660): 301–8. doi:10.1016/S0140-6736(08)61815-2.